These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 23227880)

  • 1. Removing barriers to participation in clinical trials, a conceptual framework and retrospective chart review study.
    Kanarek NF; Kanarek MS; Olatoye D; Carducci MA
    Trials; 2012 Dec; 13():237. PubMed ID: 23227880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discordant attitudes and beliefs about cancer clinical trial participation between physicians, research staff, and cancer patients.
    Hillyer GC; Beauchemin M; Hershman DL; Kelsen M; Brogan FL; Sandoval R; Schmitt KM; Reyes A; Terry MB; Lassman AB; Schwartz GK
    Clin Trials; 2020 Apr; 17(2):184-194. PubMed ID: 32009456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Patient Comorbid Conditions With Cancer Clinical Trial Participation.
    Unger JM; Hershman DL; Fleury ME; Vaidya R
    JAMA Oncol; 2019 Mar; 5(3):326-333. PubMed ID: 30629092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic Review and Meta-Analysis of the Magnitude of Structural, Clinical, and Physician and Patient Barriers to Cancer Clinical Trial Participation.
    Unger JM; Vaidya R; Hershman DL; Minasian LM; Fleury ME
    J Natl Cancer Inst; 2019 Mar; 111(3):245-255. PubMed ID: 30856272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development, acceptability, appropriateness and appeal of a cancer clinical trials implementation intervention for rural- and minority-serving urology practices.
    Ellis S; Geana M; Griebling T; McWilliams C; Gills J; Stratton K; Mackay C; Shifter A; Zganjar A; Thrasher B
    Trials; 2019 Oct; 20(1):578. PubMed ID: 31590694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Retrospective Analysis of Clinical Trial Accrual of Patients Presented in a Multidisciplinary Tumor Board at a Tertiary Health Care Center and Associated Barriers.
    Mobley EM; Swami U; Mott S; Ounda A; Milhem M; Monga V
    Oncol Res Treat; 2020; 43(5):196-203. PubMed ID: 32222709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient and physician factors associated with participation in cervical and uterine cancer trials: an NRG/GOG247 study.
    Brooks SE; Carter RL; Plaxe SC; Basen-Engquist KM; Rodriguez M; Kauderer J; Walker JL; Myers TK; Drake JG; Havrilesky LJ; Van Le L; Landrum LM; Brown CL
    Gynecol Oncol; 2015 Jul; 138(1):101-8. PubMed ID: 25937529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of Factors Affecting Successful Clinical Trial Enrollment in the Context of Three Prospective, Randomized, Controlled Trials.
    Logan JK; Tang C; Liao Z; Lee JJ; Heymach JV; Swisher SG; Welsh JW; Zhang J; Lin SH; Gomez DR
    Int J Radiat Oncol Biol Phys; 2017 Mar; 97(4):770-777. PubMed ID: 28244413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involving South Asian patients in clinical trials.
    Hussain-Gambles M; Leese B; Atkin K; Brown J; Mason S; Tovey P
    Health Technol Assess; 2004 Oct; 8(42):iii, 1-109. PubMed ID: 15488164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applying justice in clinical trials for diverse populations.
    Tilburt J; Ford JG; Howerton MW; Gary TL; Lai GY; Bolen S; Baffi C; Wilson RF; Tanpitukpongse TP; Powe NR; Bass EB; Sugarman J
    Clin Trials; 2007; 4(3):264-9. PubMed ID: 17715253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gatekeeping in cancer clinical trials in Canada: The ethics of recruiting the "ideal" patient.
    Bell JAH; Kelly MT; Gelmon K; Chi K; Ho A; Rodney P; Balneaves LG
    Cancer Med; 2020 Jun; 9(12):4107-4113. PubMed ID: 32314549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing the efficiency of trial-patient matching: automated clinical trial eligibility pre-screening for pediatric oncology patients.
    Ni Y; Wright J; Perentesis J; Lingren T; Deleger L; Kaiser M; Kohane I; Solti I
    BMC Med Inform Decis Mak; 2015 Apr; 15():28. PubMed ID: 25881112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Before Consent: Qualitative Analysis of Deliberations of Patients With Advanced Cancer About Early-Phase Clinical Trials.
    Garrett SB; Matthews TM; Abramson CM; Koenig CJ; Hlubocky FJ; Daugherty CK; Munster PN; Dohan D
    JCO Oncol Pract; 2020 Jan; 16(1):e56-e63. PubMed ID: 31603726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The doctor's duty to the elderly patient in clinical trials.
    Bayer A; Fish M
    Drugs Aging; 2003; 20(15):1087-97. PubMed ID: 14651432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recruiting terminally ill patients into non-therapeutic oncology studies: views of health professionals.
    Kleiderman E; Avard D; Black L; Diaz Z; Rousseau C; Knoppers BM
    BMC Med Ethics; 2012 Dec; 13():33. PubMed ID: 23216847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying barriers associated with enrollment of patients with lung cancer into clinical trials.
    Horn L; Keedy VL; Campbell N; Garcia G; Hayes A; Spencer B; Carbone DP; Sandler A; Johnson DH
    Clin Lung Cancer; 2013 Jan; 14(1):14-8. PubMed ID: 22591607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic Cancer Clinical Treatment Trials Accrual: A Closer Look at Participation Rates.
    Guerra CE; Kelly S; Redlinger C; Hernández P; Glanz K
    Am J Clin Oncol; 2021 Jun; 44(6):227-231. PubMed ID: 33710138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enrolling study personnel in Ebola vaccine trials: from guidelines to practice in a non-epidemic context.
    Lhomme E; Modet C; Augier A; Faye S; Dabakuyo-Yonli TS; Levy-Marchal C; D'Ortenzio E; Yazdanpanah Y; Chêne G; Beavogui AH; Richert L;
    Trials; 2019 Jul; 20(1):422. PubMed ID: 31296253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addressing clinical trials: can the multidisciplinary Tumor Board improve participation? A study from an academic women's cancer program.
    Kuroki L; Stuckey A; Hirway P; Raker CA; Bandera CA; DiSilvestro PA; Granai CO; Legare RD; Sakr BJ; Dizon DS
    Gynecol Oncol; 2010 Mar; 116(3):295-300. PubMed ID: 20042225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.